e-learning
resources
ERJ
2016
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Barriers to new drug development in respiratory disease
Brigden Grania, du Cros Philipp, Wong Sidney
Source:
Eur Respir J 2016; 47: 356-357
Journal Issue:
January
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Brigden Grania, du Cros Philipp, Wong Sidney. Barriers to new drug development in respiratory disease. Eur Respir J 2016; 47: 356-357
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Developing the pneumonia-optimized ratio for community-acquired pneumonia: an easy, inexpensive and accurate prognostic biomarker
Relationship of respiratory disorders of sleep with cognitive impairment and neurological diseases
Psychological features in smokers: A cross-sectional study using symptom checklist-90-revised
Related content which might interest you:
Delivering telemedicine interventions in chronic respiratory disease
Source: Breathe 2014; 10: 198-212
Year: 2014
Alternative training strategies for patients with chronic respiratory disease
Source: Eur Respir Monogr 2021; 93: 67-82
Year: 2021
Optimising disease models for lung diseases and drug development
Source: International Congress 2015 – Development and application of new approaches for respiratory disease research
Year: 2015
Home management of chronic respiratory disease through the use of telemedicine
Source: Annual Congress 2009 - MP18 - Home management of chronic respiratory disease through the use of telemedicine
Year: 2009
Reasons of non-adherence to telemonitoring programs in patients with chronic respiratory diseases.
Source: International Congress 2019 – Novel interventions and models of pulmonary rehabilitation
Year: 2019
Self-management of respiratory disease
Source: Respipedia Article
Year: 2018
Rational use and stewardship of antibiotics in pediatric respiratory disease
Source: ERS Courses: Paediatric respiratory infections
Year: 2019
Strategy for early diagnosis and intervention in chronic respiratory disease
Source: Virtual Congress 2020 – Chinese programme 2020: Part I
Year: 2020
From the bedside: upcoming new clinical strategies: novel strategies to combat respiratory viral infections
Source: International Congress 2017 – Scientific year in review
Year: 2017
Improving adherence in paediatric respiratory disease
Source: Breathe 2013; 9: 268-277
Year: 2013
Targeted therapy in respiratory disease
Source: Breathe, 17 (4) 210170; 10.1183/20734735.0170-2021
Year: 2021
What are the knowledge gaps in COPD that prevent new drug development?
Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD
Year: 2014
Exercise and respiratory health: improving disease consequences
Source: International Congress 2019 – The future of respiratory diseases: what prevention can do
Year: 2019
The use of technology to support integrated care of chronic respiratory disease
Source: Annual Congress 2010 - Integrated care for chronic respiratory disease
Year: 2010
Update on management of new emerging acute respiratory viral infectious diseases
Source: International Congress 2018 – Chinese Programme 2018: Part I
Year: 2018
Auditing patterns of azithromycin use in respiratory disease
Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept